Calsyntenin-1 mediates axonal transport of the amyloid precursor protein and regulates Aβ production

Understanding the mechanisms that control processing of the amyloid precursor protein (APP) to produce amyloid-β (Aβ) peptide represents a key area of Alzheimer's disease research. Here, we show that siRNA-mediated loss of calsyntenin-1 in cultured neurons alters APP processing to increase production of Aβ. We also show that calsyntenin-1 is reduced in Alzheimer's disease brains and that the extent of this reduction correlates with increased Aβ levels. Calsyntenin-1 is a ligand for kinesin-1 light chains and APP is transported through axons on kinesin-1 molecular motors. Defects in axonal transport are an early pathological feature in Alzheimer's disease and defective APP transport is known to increase Aβ production. We show that calsyntenin-1 and APP are co-transported through axons and that siRNA-induced loss of calsyntenin-1 markedly disrupts axonal transport of APP. Thus, perturbation to axonal transport of APP on calsyntenin-1 containing carriers induces alterations to APP processing that increase production of Aβ. Together, our findings suggest that disruption of calsyntenin-1-associated axonal transport of APP is a pathogenic mechanism in Alzheimer's disease.

[1]  G. Morfini,et al.  Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells , 2012, Experimental Brain Research.

[2]  Mark P. Dodding,et al.  A kinesin‐1 binding motif in vaccinia virus that is widespread throughout the human genome , 2011, The EMBO journal.

[3]  R. Huganir,et al.  Arc/Arg3.1 Regulates an Endosomal Pathway Essential for Activity-Dependent β-Amyloid Generation , 2011, Cell.

[4]  B. de Strooper,et al.  ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1 , 2011, Proceedings of the National Academy of Sciences.

[5]  K. Lau,et al.  GULP1 is a novel APP-interacting protein that alters APP processing. , 2011, The Biochemical journal.

[6]  Alessio Vagnoni,et al.  Phosphorylation of kinesin light chain 1 at serine 460 modulates binding and trafficking of calsyntenin-1 , 2011, Journal of Cell Science.

[7]  B. Gerrits,et al.  Molecular characterization of a trafficking organelle: Dissecting the axonal paths of calsyntenin‐1 transport vesicles , 2010, Proteomics.

[8]  J. Bonifacino,et al.  Sorting of the Alzheimer's disease amyloid precursor protein mediated by the AP-4 complex. , 2010, Developmental cell.

[9]  B. Strooper,et al.  The secretases: enzymes with therapeutic potential in Alzheimer disease , 2010, Nature Reviews Neurology.

[10]  M. Perkinton,et al.  Amyloid precursor protein 695 associates with assembled NR2A‐ and NR2B‐containing NMDA receptors to result in the enhancement of their cell surface delivery , 2009, Journal of neurochemistry.

[11]  K. Lau,et al.  X11beta rescues memory and long-term potentiation deficits in Alzheimer's disease APPswe Tg2576 mice. , 2009, Human molecular genetics.

[12]  K. Beyreuther,et al.  APP Anterograde Transport Requires Rab3A GTPase Activity for Assembly of the Transport Vesicle , 2009, The Journal of Neuroscience.

[13]  Yuyu Song,et al.  Axonal Transport Defects in Neurodegenerative Diseases , 2009, The Journal of Neuroscience.

[14]  N. Hirokawa,et al.  Kinesin superfamily motor proteins and intracellular transport , 2009, Nature Reviews Molecular Cell Biology.

[15]  P. Sonderegger,et al.  Calsyntenins Mediate TGN Exit of APP in a Kinesin‐1‐Dependent Manner , 2009, Traffic.

[16]  B. Lamb,et al.  The Cleavage Products of Amyloid-β Precursor Protein Are Sorted to Distinct Carrier Vesicles That Are Independently Transported within Neurites , 2009, Journal of Neuroscience.

[17]  T. Südhof,et al.  Deletion of Mint Proteins Decreases Amyloid Production in Transgenic Mouse Models of Alzheimer's Disease , 2008, The Journal of Neuroscience.

[18]  E. Koo,et al.  Amyloid Precursor Protein Trafficking, Processing, and Function* , 2008, Journal of Biological Chemistry.

[19]  A. Grierson,et al.  Role of axonal transport in neurodegenerative diseases. , 2008, Annual review of neuroscience.

[20]  Ralph A. Nixon,et al.  Autophagy, amyloidogenesis and Alzheimer disease , 2007, Journal of Cell Science.

[21]  C. Shaw,et al.  Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. , 2007, Human molecular genetics.

[22]  D. Selkoe,et al.  Aβ Oligomers – a decade of discovery , 2007, Journal of neurochemistry.

[23]  Yu Ohsugi,et al.  The novel cargo Alcadein induces vesicle association of kinesin‐1 motor components and activates axonal transport , 2007, The EMBO journal.

[24]  K. Beyreuther,et al.  PAT1a Modulates Intracellular Transport and Processing of Amyloid Precursor Protein (APP), APLP1, and APLP2* , 2006, Journal of Biological Chemistry.

[25]  Y. Sano,et al.  Enhanced Amyloidogenic Metabolism of the Amyloid β-Protein Precursor in the X11L-deficient Mouse Brain* , 2006, Journal of Biological Chemistry.

[26]  S. Small,et al.  Sorting through the Cell Biology of Alzheimer's Disease: Intracellular Pathways to Pathogenesis , 2006, Neuron.

[27]  P. Sonderegger,et al.  Calsyntenin-1 docks vesicular cargo to kinesin-1. , 2006, Molecular biology of the cell.

[28]  E. Mandelkow,et al.  Inhibition of APP Trafficking by Tau Protein Does Not Increase the Generation of Amyloid‐β Peptides , 2006, Traffic.

[29]  L. Goldstein,et al.  Axonal transport and Alzheimer's disease. , 2006, Annual review of biochemistry.

[30]  K. Lau,et al.  The X11 proteins, Aβ production and Alzheimer's disease , 2006, Trends in Neurosciences.

[31]  Z. Muresan,et al.  Coordinated transport of phosphorylated amyloid-β precursor protein and c-Jun NH2-terminal kinase–interacting protein-1 , 2005, The Journal of cell biology.

[32]  D. Selkoe,et al.  Physiological Regulation of the β-Amyloid Precursor Protein Signaling Domain by c-Jun N-Terminal Kinase JNK3 during Neuronal Differentiation , 2005, The Journal of Neuroscience.

[33]  E. Masliah,et al.  Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.

[34]  E. Mandelkow,et al.  MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons , 2004, The Journal of cell biology.

[35]  K. Lau,et al.  The Neuronal Adaptor Protein X11β Reduces Amyloid β-Protein Levels and Amyloid Plaque Formation in the Brains of Transgenic Mice* , 2004, Journal of Biological Chemistry.

[36]  S. Tomita,et al.  Novel Cadherin-related Membrane Proteins, Alcadeins, Enhance the X11-like Protein-mediated Stabilization of Amyloid β-Protein Precursor Metabolism* , 2003, Journal of Biological Chemistry.

[37]  M. Ward,et al.  The neuronal adaptor protein Fe65 is phosphorylated by mitogen-activated protein kinase (ERK1/2) , 2003, Molecular and Cellular Neuroscience.

[38]  J. Cooper,et al.  The Neuronal Adaptor Protein X11α Reduces Aβ Levels in the Brains of Alzheimer's APPswe Tg2576 Transgenic Mice* , 2003, Journal of Biological Chemistry.

[39]  D. Selkoe,et al.  Functional γ-secretase complex assembly in Golgi/trans-Golgi network: interactions among presenilin, nicastrin, Aph1, Pen-2, and γ-secretase substrates , 2003, Neurobiology of Disease.

[40]  L. Tsai,et al.  APP processing is regulated by cytoplasmic phosphorylation , 2003, The Journal of cell biology.

[41]  A. Levey,et al.  Munc18 Interacting Proteins , 2003, Journal of Biological Chemistry.

[42]  C. Shaw,et al.  Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments , 2003, The Journal of cell biology.

[43]  Y. Kirino,et al.  Phosphorylation-dependent Regulation of the Interaction of Amyloid Precursor Protein with Fe65 Affects the Production of β-Amyloid* , 2001, The Journal of Biological Chemistry.

[44]  K. Lau,et al.  Phosphorylation of thr668 in the cytoplasmic domain of the Alzheimer's disease amyloid precursor protein by stress‐activated protein kinase 1b (Jun N‐terminal kinase‐3) , 2001 .

[45]  L. Goldstein,et al.  Axonal Transport of Amyloid Precursor Protein Is Mediated by Direct Binding to the Kinesin Light Chain Subunit of Kinesin-I , 2000, Neuron.

[46]  D. Selkoe,et al.  Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid beta-protein generation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  C. Kaether,et al.  Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons. , 2000, Molecular biology of the cell.

[48]  R. Doms,et al.  Protein Kinase C-dependent α-Secretase Competes with β-Secretase for Cleavage of Amyloid-β Precursor Protein in the Trans-Golgi Network* , 2000, The Journal of Biological Chemistry.

[49]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[50]  D. Selkoe,et al.  Mutagenesis Identifies New Signals for β-Amyloid Precursor Protein Endocytosis, Turnover, and the Generation of Secreted Fragments, Including Aβ42* , 1999, The Journal of Biological Chemistry.

[51]  S. Tomita,et al.  Interaction of a Neuron-specific Protein Containing PDZ Domains with Alzheimer’s Amyloid Precursor Protein* , 1999, The Journal of Biological Chemistry.

[52]  S. Pimplikar,et al.  PAT1, a microtubule-interacting protein, recognizes the basolateral sorting signal of amyloid precursor protein. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[53]  C. Miller,et al.  The intracellular cytoplasmic domain of the Alzheimer's disease amyloid precursor protein interacts with phosphotyrosine-binding domain proteins in the yeast two-hybrid system. , 1996, FEBS letters.

[54]  B. Margolis,et al.  The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein , 1996, Molecular and cellular biology.

[55]  S. Squazzo,et al.  Evidence that production and release of amyloid beta-protein involves the endocytic pathway. , 1994, The Journal of biological chemistry.

[56]  D. Selkoe,et al.  Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.

[57]  K. Lau,et al.  The X11 proteins, Abeta production and Alzheimer's disease. , 2006, Trends in neurosciences.

[58]  J. Cooper,et al.  The neuronal adaptor protein X11alpha reduces Abeta levels in the brains of Alzheimer's APPswe Tg2576 transgenic mice. , 2003, The Journal of biological chemistry.

[59]  D. Selkoe,et al.  Functional gamma-secretase complex assembly in Golgi/trans-Golgi network: interactions among presenilin, nicastrin, Aph1, Pen-2, and gamma-secretase substrates. , 2003, Neurobiology of disease.

[60]  D. Selkoe,et al.  Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. , 1999, The Journal of biological chemistry.

[61]  D. Teplow,et al.  Amyloid beta-peptide is produced by cultured cells during normal metabolism. , 1992, Nature.